These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36030976)
1. Native PLGA nanoparticles regulate APP metabolism and protect neurons against β-amyloid toxicity: Potential significance in Alzheimer's disease pathology. Wu Q; Karthivashan G; Nakhaei-Nejad M; Anand BG; Giuliani F; Kar S Int J Biol Macromol; 2022 Oct; 219():1180-1196. PubMed ID: 36030976 [TBL] [Abstract][Full Text] [Related]
2. Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer's disease pathology. Paul PS; Cho JY; Wu Q; Karthivashan G; Grabovac E; Wille H; Kulka M; Kar S J Nanobiotechnology; 2022 Feb; 20(1):67. PubMed ID: 35120558 [TBL] [Abstract][Full Text] [Related]
3. Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β-amyloid-toxicity. Wang Y; Wu Q; Anand BG; Karthivashan G; Phukan G; Yang J; Thinakaran G; Westaway D; Kar S Neuropathol Appl Neurobiol; 2020 Dec; 46(7):686-706. PubMed ID: 32716575 [TBL] [Abstract][Full Text] [Related]
4. Native PLGA nanoparticles attenuate Aβ-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer's disease pathology. Paul PS; Patel T; Cho JY; Yarahmady A; Khalili A; Semenchenko V; Wille H; Kulka M; Mok SA; Kar S Sci Rep; 2024 Jan; 14(1):144. PubMed ID: 38167993 [TBL] [Abstract][Full Text] [Related]
5. Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology. Anand B; Wu Q; Nakhaei-Nejad M; Karthivashan G; Dorosh L; Amidian S; Dahal A; Li X; Stepanova M; Wille H; Giuliani F; Kar S Bioact Mater; 2022 Nov; 17():506-525. PubMed ID: 36330076 [TBL] [Abstract][Full Text] [Related]
6. Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of alzheimer's disease. Govindarajan K; Kar S J Nanobiotechnology; 2023 Jul; 21(1):216. PubMed ID: 37424018 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer's disease-related pathology in 5XFAD mice. Jeon SG; Cha MY; Kim JI; Hwang TW; Kim KA; Kim TH; Song KC; Kim JJ; Moon M Nanomedicine; 2019 Apr; 17():297-307. PubMed ID: 30794963 [TBL] [Abstract][Full Text] [Related]
8. Phytol loaded PLGA nanoparticles regulate the expression of Alzheimer's related genes and neuronal apoptosis against amyloid-β induced toxicity in Neuro-2a cells and transgenic Caenorhabditis elegans. Sathya S; Shanmuganathan B; Balasubramaniam B; Balamurugan K; Devi KP Food Chem Toxicol; 2020 Feb; 136():110962. PubMed ID: 31734340 [TBL] [Abstract][Full Text] [Related]
9. APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease. Maulik M; Peake K; Chung J; Wang Y; Vance JE; Kar S Hum Mol Genet; 2015 Dec; 24(24):7132-50. PubMed ID: 26433932 [TBL] [Abstract][Full Text] [Related]
10. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology. Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769 [TBL] [Abstract][Full Text] [Related]
11. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ. Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668 [TBL] [Abstract][Full Text] [Related]
12. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis. Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Tripoli DL; Czerniewski L; Ballabio A; Cirrito JR; Diwan A; Lee JM J Neurosci; 2015 Sep; 35(35):12137-51. PubMed ID: 26338325 [TBL] [Abstract][Full Text] [Related]
13. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199 [TBL] [Abstract][Full Text] [Related]
14. Phytol-loaded PLGA nanoparticle as a modulator of Alzheimer's toxic Aβ peptide aggregation and fibrillation associated with impaired neuronal cell function. Sathya S; Shanmuganathan B; Saranya S; Vaidevi S; Ruckmani K; Pandima Devi K Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1719-1730. PubMed ID: 29069924 [TBL] [Abstract][Full Text] [Related]
15. Effects of cholesterol transport inhibitor U18666A on APP metabolism in rat primary astrocytes. Yang H; Wang Y; Kar S Glia; 2017 Nov; 65(11):1728-1743. PubMed ID: 28722194 [TBL] [Abstract][Full Text] [Related]
16. Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. Xiao Q; Gil SC; Yan P; Wang Y; Han S; Gonzales E; Perez R; Cirrito JR; Lee JM J Biol Chem; 2012 Jun; 287(25):21279-89. PubMed ID: 22539346 [TBL] [Abstract][Full Text] [Related]
17. Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy. Joshi G; Gan KA; Johnson DA; Johnson JA Neurobiol Aging; 2015 Feb; 36(2):664-79. PubMed ID: 25316599 [TBL] [Abstract][Full Text] [Related]
18. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
19. Intracellular amyloid precursor protein sorting and amyloid-β secretion are regulated by Src-mediated phosphorylation of Mint2. Chaufty J; Sullivan SE; Ho A J Neurosci; 2012 Jul; 32(28):9613-25. PubMed ID: 22787047 [TBL] [Abstract][Full Text] [Related]
20. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]